Aim: A multicenter, retrospective survey was conducted in order to investigate the current clinical status of adenomyosis in Japan.
and limited to small-scale cases, the impact of adenomyosis on female fertility is still unclear.
Although substantial effort has been focused on improving the reproductive outcomes by pretreatment for adenomyosis, there is presently no evidence to suggest the potential benefit of medication or surgical intervention, in terms of the fertility prognosis. 15 Multiple treatment modalities, including hormonal therapy with gonadotropinreleasing hormone (GnRH) agonists and conservative surgical procedures, for women with adenomyosis have been used to restore their fertility. Although successful pregnancies after prolonged downregulation with GnRH agonists 16, 17 and conservative surgery have been reported, [18] [19] [20] there is no agreement on the most appropriate therapeutic method for managing infertile patients with adenomyosis.
In addition, the size and type of adenomyosis are considered to be important factors that affect fertility. Adenomyosis can be classified into two categories: focal adenomyosis, which is a restricted area of hypertrophic and distorted endometrium and myometrium, usually embedded within the myometrium; and diffuse adenomyosis, which is the extensive form of the disease, characterized by foci of endometrial mucosa (glands and stroma) scattered throughout the uterine musculature. 21 There are presently no available data to analyze the relationship between the type of adenomyosis and infertility.
In order to investigate the current clinical status of adenomyosis in Japan, a nationwide survey was conducted. A multicenter, retrospective survey of infertility patients with adenomyosis was performed to demonstrate the prevalence, clinical features, treatments, and outcomes of infertility therapy in women with adenomyosis in Japan.
| MATERIALS AND METHODS
Between October, 2011 and March, 2012 a nationwide survey was conducted in order to evaluate the impact of adenomyosis on infertility treatment and pregnancy outcomes as an official project of the Japan Society of Obstetrics and Gynecology (JSOG). A retrospective survey was performed by using questionnaires that were sent to 1149 Japanese medical facilities, including 725 institutes that were authorized as training facilities by JSOG and 582 institutes that were registered to JSOG for assisted reproductive technology (ART). Two questionnaires were mailed to all the facilities seeking their cooperation for this survey in order to perform a retrospective analysis based on the clinical records of each facility.
Questionnaire 1 inquired about the management policy for infertile women with adenomyosis and Questionnaire 2 inquired about the outcomes of infertility treatment in women with adenomyosis.
In order to investigate the management policy of each facility for infertile women with adenomyosis, Questionnaire 1 inquired about the strategy for infertility treatment, including no pretreatment or the application of medication, a conservative operation, uterine artery embolization, and others before infertility treatment, or no established strategy (dependent on the individual situation). In order to analyze the impact of adenomyosis on infertility treatment, Questionnaire 2 inquired about the number of infertility patients with adenomyosis, methods of the diagnosis, size (major axis), type (focal or diffuse), localization (anterior wall or posterior wall), infertility treatment, and outcome of the infertility treatments. Questionnaire 2 also assessed any pretreatment for adenomyosis before infertility treatment.
In this survey, patients with myoma of the uterus and endometriosis were excluded in order to eliminate the influence of these diseases on fertility. 
| RESULTS
The questionnaires were sent to 1149 facilities in Japan and were filled out by 190 facilities (response rate: 16.5%).
| Questionnaire 1
The Questionnaire 1 results were obtained from 155 facilities (Table 1) . Of the 155 facilities, infertility treatment was performed without any pretreatment for adenomyosis in 37 facilities (23.9%).
Infertility treatment was performed after medication for adenomyosis in eight facilities (5.2%) and the medications were as follows: GnRH agonists in six facilities and Dienogest in two facilities. Infertility treatment was performed after an operation in four facilities (2.6%) and management policies were not established (dependent on individual situations) in 106 facilities (68.4%).
| Questionnaire 2
The (Table 2 ).
In order to analyze the relationship between the size of the adenomyosis and the clinical outcomes in women with infertility treatment, the women were divided into four groups (<40 mm, 40-60 mm, 60-80 mm, >80 mm), depending on the size of the focus. 60 mm, 60-80 mm, and >80 mm groups, respectively. There were no significant differences in the pregnancy and miscarriage rates among the four groups ( Table 3) . 32.3%) were not affected by pretreatment for adenomyosis ( Figure 1 ). 
| DISCUSSION
The present study is the first to conduct a large-scale, nationwide survey on the relationship between adenomyosis and infertility treatment. This study found that most Japanese facilities do not have a strategy for managing infertile women with adenomyosis, suggesting that a standard management policy has not been established. The association of adenomyosis with female fertility varies widely among individuals because the condition of the disease varies in size, type, localization, and severity. The presence of a concomitant pathology, including leiomyoma (35%-55%) and endometriosis (6%-20%), might drastically influence the fertility of women with adenomyosis.
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As a high prevalence of endometriosis in women with adenomyosis was observed in the majority of the articles that reported on adenomyosis and fertility, the actual impact of the disease on female fertility is difficult to determine. Therefore, women with endometriosis and leiomyoma were excluded from this study.
A systematic review and meta-analysis showed that women with adenomyosis had a significantly lower clinical pregnancy rate (relative twofold increased risk of miscarriage (RR: 2.12; 95% CI: 1.20-3.75) than those without adenomyosis. 25 rates were not affected by adenomyosis; furthermore, the endometrial gene expression profile that is involved in the implantation process and the endometrial receptivity of women with adenomyosis did not differ markedly from those of the controls. 13 However, these studies used varying criteria for the diagnosis of adenomyosis and the majority did not quantify the severity. The heterogeneity among the selected studies was also high due to the age of the participants, duration of infertility, coexistence of endometriosis and leiomyoma, protocol of IVF/ ICSI, number and stage of transferred embryos, and number of IVF/ ICSI cycles that was carried out. Therefore, exploring or studying the correlation between adenomyosis and fertility problems is difficult.
The present results show that the pregnancy rate from infertility treatment in women with adenomyosis is about 40%. The impact of adenomyosis on female fertility is unclear because the pregnancy rate could not be compared with control participants (those without adenomyosis) in this survey. However, this study's results are consistent with those of previous reports that showed the pregnancy rates (40%-50%) in women with adenomyosis, 25, 38 suggesting that a considerable pregnancy rate would be expected in infertile women with adenomyosis. In addition, not only ART but also the usual infertility treatments without ART showed almost the same pregnancy rate (non-ART: 37.5%; ART: 44.4%). The present results suggest that ART might not necessarily be required for the first-step management of infertile women with adenomyosis.
The association of adenomyosis with an increased risk of miscarriage also has been suggested. The miscarriage rates in this survey were about 30% and no significant correlation was observed between the rates and pretreatment and size and type of adenomyosis.
However, almost the same miscarriage rates in this study also were reported in several other studies. A miscarriage rate was observed in 31.8% (21/66) of the pregnancies in women with adenomyosis and in 12.5% (29/224) in those without adenomyosis, 10 while also in 32.8%
(43/131) of women with adenomyosis and in 16.3% of the (24/147) controls. 13 These reports showed that the miscarriage rates were higher in women with adenomyosis than in those without adenomyosis. However, the factors that contribute to adenomyosis-related miscarriage could not be adequately assessed. In this regard, alterations in the inner myometrium of women with adenomyosis might result in defective remodeling of the spiral arteries during the decidualization process. 39 Further studies are required to properly evaluate the relationship between adenomyosis and pregnancy outcomes.
It is not known whether or not an improvement in reproductive performance can be achieved after the use of medical and/or surgical management. Case reports and small series studies have reported successful pregnancies after long-term GnRH agonist treatment. [40] [41] [42] However, there has been no large-scale study that has evaluated the efficacy of GnRH agonists before fertility treatment in women with adenomyosis. Of the 85 patients who had received medication before infertility treatment, 67 had received GnRH agonists in this survey. The pregnancy rate (43.5%) and miscarriage rate (31.7%) were not markedly different from the no-pretreatment group (41.3% and 30.3%, respectively). There were no data to suggest that medication as a pretreatment for adenomyosis increased the pregnancy rate in infertile women.
Although conservative surgery has not become the standard treatment for adenomyosis, successful pregnancies after conservative surgery in women with adenomyosis have been reported. The advantages of removing the affected area must be balanced against the disadvantages of leaving a possibly defective uterine wall. To the authors' knowledge, there are no data that assess the relationship between the size of adenomyosis and female fertility. A large adenomyosis probably can cause deformity of the uterine cavity and might impair implantation via the biological mechanisms described above. A recent report found a relationship between the uterine wall thickness (>15 mm) and the miscarriage rate in women with diffusetype adenomyosis. 46 However, the size of adenomyosis was evaluated by the major axis of the focus, as a simple and objective indication for both types (focal and diffuse) in this survey. There was no significant relationship between the size of adenomyosis and the pregnancy rate. and implantation and an increased risk of early pregnancy loss. 25 However, a high prevalence of endometriosis in women with adenomyosis was observed in the majority of these articles that reported on adenomyosis and fertility. Therefore, studies need to discriminate between women with adenomyosis only and those with endometriosis in addition to adenomyosis. Women with coexisting endometriosis and leiomyoma were excluded from the present survey in order to improve the understanding of the association between adenomyosis and infertility. It was found that the pregnancy rate with infertility treatment for infertile women with adenomyosis was about 40% and the miscarriage rate was about 30%. Almost the same pregnancy rates with infertility treatment were observed between the ART and non-ART subgroups,
suggesting that ART might not necessarily be required for the firststep management of infertile women with adenomyosis. Neither the size nor the type of adenomyosis showed any association with the reproductive outcome. In addition, there were no data to suggest that medication or surgery as a pretreatment for adenomyosis improved the reproductive outcome. The data from this survey were not sufficient to analyze the actual relationship between adenomyosis and fertility because the response rate of this survey was low (16.5%; 190/1149 facilities). A prospective and well-conducted randomized study is required to evaluate the true effect of adenomyosis on fertility outcomes.
